MedPage Today

Akeega Approved for BRCA2-Mutated Prostate Cancer

The FDA approved niraparib and abiraterone acetate (Akeega) in combination with prednisone for treating BRCA2 -mutated ...
CURE

FDA Approves Akeega Combo in BRCA2+ Metastatic Prostate Cancer

The U.S. Food and Drug Administration (FDA) has approved niraparib (Zejula) plus Akeega (abiraterone acetate) and prednisone ...

Women’s health: What common symptoms are often ignored until it’s serious

Women often dismiss subtle health cues like fatigue or pain, leading to delayed diagnoses for serious conditions like heart disease and endometriosis. Studies show women downplay symptoms more than ...

How to (ouch!) relieve pain on the bottom of your foot

Here’s what to know about how common bottom-of-foot pain is, why it happens and the most reliable ways to find relief.
The Clinton Herald

TO YOUR GOOD HEALTH: Osteoboost belt needs more study before being recommended

I am a 68-year-old female who was first diagnosed with osteopenia and now osteoporosis. My physician has highly recommended ...
The Malaysian Reserve

U.S. FDA approves AKEEGA® as the first precision therapy for BRCA2-mutated metastatic castration-sensitive prostate cancer with 54% reduction in disease progression vs ...

Expanded indication for AKEEGA® (niraparib and abiraterone acetate dual-action tablet) plus prednisone marks the first FDA-approved precision medicine ...